The Washington PostDemocracy Dies in Darkness

CDC tells states to plan for coronavirus vaccine as early as Nov. 1, raising concerns of political pressure

The United States began Phase 3, one of the last steps in developing a vaccine, on July 27, 2020. We take you inside the process. (Video: The Washington Post)
Placeholder while article actions load
Please Note

The Washington Post is providing this important information about the coronavirus for free. For more free coverage of the coronavirus pandemic, sign up for our Coronavirus Updates newsletter where all stories are free to read.

The Centers for Disease Control and Prevention has told public health officials in all 50 states and the U.S. territories to plan to distribute a coronavirus vaccine to health-care workers and other high-priority groups as early as Nov. 1, according to CDC guidance. The timeline for possible early distribution has raised concerns that the Food and Drug Administration is rushing to approve a vaccine before Election Day.

View live politics updates

Here are some significant developments:

  • House Speaker Nancy Pelosi responded to criticism of her trip to a San Francisco hair salon — which was not cleared to reopen for indoor service and where she appeared momentarily maskless. Her defense: “It was a setup.”
  • By the end of 2020, the amount of debt owed by the United States will amount to 98 percent of the nation’s gross domestic product, the highest level since the end of World War II, the nonpartisan Congressional Budget Office said.
  • Cheap, widely available steroid drugs reduced the number of deaths in the sickest patients with covid-19, according to three newly published clinical trials.
  • A Minnesota biker who attended the Sturgis Motorcycle Rally has died of covid-19 — the first fatality from the virus traced to the 10-day event that drew more than 400,000 people to South Dakota. His is among at least 260 cases in 11 states tied directly to the event.
  • A study out of Iceland found that coronavirus antibodies lasted for at least four months, which could be good news for vaccine development efforts.

Sign up for our coronavirus newsletter | Mapping the spread of the coronavirus: Across the U.S. | Worldwide | Vaccine tracker | Where states reopened and cases spiked | Has someone close to you died of covid-19? Share your story with The Washington Post.